News
Following an executive reset, the Tokyo firm hopes to grow its molecular and immunochemical testing businesses.
The DOJ alleged Agendia submitted false claims to Medicare, Medicaid, and other government payors for its MammaPrint breast cancer test.
Investors and consultants in the space said that they have seen rising enthusiasm among investors as recent funding rounds ...
The firm presented data at AACR that showed the test had high accuracy when distinguishing ovarian cancer at early stages.
NEW YORK – Tribun Health said Tuesday that it has secured US Food and Drug Administration 510(k) marketing clearance for the use of its image management system with whole-slide imaging scanners from ...
NEW YORK – A team led by investigators at Institut Pasteur has commenced work on a new lateral flow assay that could be used to detect the presence of the malaria-causing parasite Plasmodium vivax in ...
Tempus' FDA-approved xT CDx test is being used as an investigational assay in Verastem's global Phase 3 RAMP-301 clinical trial.
Among other impacts, the committee's closure could hamper efforts to modernize CLIA regulations, which has been a priority among many in the clinical lab space.
University of Birmingham Team Developing Point-of-Care Test for Multiple Myeloma Precursor Condition
The lateral flow, fingerprick blood test measures monoclonal proteins, with results that can be read on a phone app.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results